「one droptwice」の検索結果
26件：21～25件目を表示
もしかして
-
ミケランLA点眼液 添付文書 2022年3月改訂 TD75X2B17
de （JAN） 〕 化学名：5- ［(2RS)-3-(1,1-Dimethylethyl)amino-2- hydroxypropyloxy］ -3,4-dihydroquinolin-2(1H)-one monohydrochloride 分子式：C16H24N2O3・HCl 分子量：328.83 性状：白色の結晶又は結晶性の粉末である。水にやや溶けやす く、メタノールにやや溶けにくく、エタノ...
https://www.senju.co.jp/system/files/product_other_file/2022-03/MKLA_17_20220330_0.pdf -
safety, no serious adverse effects were observed with the new formulation, similar to the previous one. Adverse effects such as allergic conjunctivitis and conjunctival hyperemia, which have been rep...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904_0.pdf -
ing authorization holder is Rexxam Co., Ltd. (hereinafter “Rexxam”). 3in1 Smart is a compact all-in-one unit that integrates refractometry, keratometry, and tonometry into a single device, consolidati...
https://www.senju.co.jp/system/files/content_news/2026-05/ENG_20260601.pdf -
safety, no serious adverse effects were observed with the new formulation, similar to the previous one. Adverse effects such as allergic conjunctivitis and conjunctival hyperemia, which have been rep...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf -
Product Development Policy | Research & Development | SENJU Pharmaceutica
Product Strategy DivisionExecutive OfficerYasunobu Maenaka With the management philosophy of “Good Company” and a company that shapes “Beyond eyesight,” Senju Pharmaceutical has developed products tha...
http://www.senju.co.jp/english/rd/policy/